Aiming to become the global leader in chip-scale photonic solutions by deploying Optical Interposer technology to enable the seamless integration of electronics and photonics for a broad range of vertical market applications

Free
Message: and on other fronts
regarding Renova Health. Could Poet acquire them as an avenue to sell a health device that they are working on? There was someone that posted on here about a device being tested at a hospital in Ontario. All along Poet has said they may make more acquisitions. Does anyone remember at the THM they talked about a glucose testing device that did not require that a person poke themselves? If they have one of those, that would be huge. It was a DenseLight product. I always thought it was funny they closed the DenseLight deal in Toronto. Did they start a trial at a hospital in Ontario at that time?
Share
New Message
Please login to post a reply